Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

16.24USD
4 Sep 2015
Change (% chg)

$-0.29 (-1.75%)
Prev Close
$16.53
Open
$16.30
Day's High
$16.43
Day's Low
$16.01
Volume
1,543,696
Avg. Vol
2,046,411
52-wk High
$18.61
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $21,825.86
Shares Outstanding(Mil.): 1,343.96
Dividend: --
Yield (%): --

Financials

Search Stocks

Boston Scientific's stent approved for peripheral artery disease

- Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the country due to partial or no deployments.

20 Aug 2015

UPDATE 1-Boston Scientific's stent approved for peripheral artery disease

Aug 19 - Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the country due to partial or no deployments.

20 Aug 2015

Special Report - Investors profit by funding surgery for desperate women patients

NEW YORK - In July 2013, California urogynecologist Andrew Cassidenti received an email from an entrepreneur named Otto Fisher, who had a proposition. Fisher was looking for surgeons to perform operations to remove pelvic mesh implants from women.

18 Aug 2015

SPECIAL REPORT-Investors profit by funding surgery for desperate women patients

NEW YORK, Aug 18 - In July 2013, California urogynecologist Andrew Cassidenti received an email from an entrepreneur named Otto Fisher, who had a proposition. Fisher was looking for surgeons to perform operations to remove pelvic mesh implants from women.

18 Aug 2015

UPDATE 1-Boston Scientific cuts profit forecast again as legal costs mount

July 23 - Boston Scientific Corp cut its full-year profit forecast for the second time in the face of rising litigation costs linked to problems with its implantable device used to treat feminine stress urinary incontinence.

23 Jul 2015

Boston Scientific profit soars

July 23 - Medical device maker Boston Scientific Corp, dogged by litigation expenses last year, reported a jump in quarterly profit.

23 Jul 2015

Boston Scientific ordered to pay $100 million in transvaginal mesh trial

- A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 lawsuits against the company.

29 May 2015

UPDATE 3-Boston Scientific ordered to pay $100 mln in transvaginal mesh trial

May 28 - A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 lawsuits against the company.

29 May 2015

U.S. jury orders Boston Scientific to pay $100 mln in transvaginal mesh trial

May 28 - A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 lawsuits against the company.

28 May 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters May 5, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, no click on Related Co Data, now click on Co Events. ** For

05 May 2015

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $43.07 -1.07
St. Jude Medical, Inc. (STJ.N) $69.64 -0.74

Earnings vs. Estimates

Search Stocks